Coloplast A/S COLO B.CO · DKK

Health Care · Nasdaq Copenhagen · 🇩🇰 Denmark

Compare

496.70

-2.26%

Close of 9 Nov 2026, in DKK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in DKK, from our data supplier.

FY2025

Revenue

DKK 27.87bn

FY2016FY2025

Net income

DKK 3.64bn

FY2016FY2025

Free cash flow

DKK 5.34bn

FY2016FY2025

Shareholders' equity

DKK 16.12bn

FY2016FY2025

Income statement

Fiscal years

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Revenue	DKK 27.87bn	DKK 27.03bn	DKK 24.50bn	DKK 22.58bn	DKK 19.43bn	DKK 18.54bn	DKK 17.94bn	DKK 16.45bn	DKK 15.53bn	DKK 14.68bn
Gross profit	DKK 18.14bn	DKK 18.27bn	DKK 16.33bn	DKK 15.53bn	DKK 13.31bn	DKK 12.61bn	DKK 12.15bn	DKK 11.07bn	DKK 10.57bn	DKK 10.03bn
Research and development	DKK 900.0m	DKK 866.0m	DKK 872.0m	DKK 866.0m	DKK 755.0m	DKK 708.0m	DKK 692.0m	DKK 640.0m	DKK 574.0m	DKK 509.0m
Operating income	DKK 7.58bn	DKK 7.32bn	DKK 6.77bn	DKK 6.44bn	DKK 6.36bn	DKK 5.85bn	DKK 5.16bn	DKK 5.09bn	DKK 5.02bn	DKK 4.10bn
Net income	DKK 3.64bn	DKK 5.05bn	DKK 4.78bn	DKK 4.71bn	DKK 4.83bn	DKK 4.20bn	DKK 3.87bn	DKK 3.85bn	DKK 3.80bn	DKK 3.14bn
Diluted earnings per share	16.16	22.42	21.89	22.16	22.63	19.73	18.16	18.08	17.85	14.82

Balance sheet

At each fiscal year end

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Total assets	DKK 48.37bn	DKK 48.07bn	DKK 48.16bn	DKK 34.96bn	DKK 15.84bn	DKK 13.50bn	DKK 12.73bn	DKK 11.77bn	DKK 12.05bn	DKK 11.01bn
Cash and short-term investments	DKK 947.0m	DKK 788.0m	DKK 911.0m	DKK 633.0m	DKK 674.0m	DKK 585.0m	DKK 669.0m	DKK 607.0m	DKK 629.0m	DKK 1.03bn
Total liabilities	DKK 32.24bn	DKK 30.13bn	DKK 30.86bn	DKK 26.66bn	DKK 7.67bn	DKK 6.09bn	DKK 5.82bn	DKK 5.35bn	DKK 6.10bn	DKK 5.94bn
Debt	DKK 22.64bn	DKK 22.63bn	DKK 19.57bn	DKK 18.71bn	DKK 2.79bn	DKK 1.75bn	DKK 1.21bn	DKK 1.36bn	DKK 1.46bn	DKK 222.0m
Shareholders' equity	DKK 16.12bn	DKK 17.94bn	DKK 17.30bn	DKK 8.29bn	DKK 8.17bn	DKK 7.41bn	DKK 6.91bn	DKK 6.42bn	DKK 5.95bn	DKK 5.07bn
Shares outstanding	225m	225m	219m	212m	213m	213m	213m	213m	213m	212m

Cash flow

Fiscal years

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Cash from operations	DKK 6.64bn	DKK 2.77bn	DKK 4.23bn	DKK 5.10bn	DKK 5.29bn	DKK 4.76bn	DKK 4.36bn	DKK 4.36bn	DKK 3.25bn	DKK 3.03bn
Capital spending	−DKK 1.31bn	−DKK 1.17bn	−DKK 1.24bn	−DKK 1.14bn	−DKK 1.97bn	−DKK 931.0m	−DKK 636.0m	−DKK 669.0m	−DKK 685.0m	−DKK 649.0m
Free cash flow	DKK 5.34bn	DKK 1.60bn	DKK 2.98bn	DKK 3.96bn	DKK 3.32bn	DKK 3.83bn	DKK 3.72bn	DKK 3.69bn	DKK 2.57bn	DKK 2.38bn
Dividends paid	−DKK 4.96bn	−DKK 4.72bn	−DKK 4.25bn	−DKK 4.04bn	−DKK 3.83bn	−DKK 3.61bn	−DKK 3.40bn	−DKK 3.29bn	−DKK 2.86bn	−DKK 2.65bn

Latest quarters

By quarter end

	Jun 2026	Mar 2026	Dec 2025	Sept 2025	Jun 2025	Mar 2025	Dec 2024	Sept 2024
Revenue	DKK 7.36bn	DKK 7.08bn	DKK 7.04bn	DKK 6.96bn	DKK 6.96bn	DKK 6.93bn	DKK 7.03bn	DKK 6.95bn
Gross profit	DKK 4.91bn	DKK 3.04bn	DKK 4.74bn	DKK 3.95bn	DKK 4.71bn	DKK 4.73bn	DKK 4.75bn	DKK 4.64bn
Operating income	DKK 1.90bn	DKK 1.80bn	DKK 1.85bn	DKK 1.94bn	DKK 1.83bn	DKK 1.89bn	DKK 1.91bn	DKK 1.91bn
Net income	DKK 1.46bn	−DKK 971.0m	DKK 1.40bn	DKK 875.0m	DKK 805.0m	DKK 912.0m	DKK 1.04bn	DKK 1.31bn
Diluted earnings per share	6.49	-4.31	6.21	3.89	3.58	4.05	4.63	5.83
Cash from operations	DKK 1.71bn	DKK 1.47bn	DKK 2.23bn	DKK 2.27bn	DKK 1.63bn	DKK 742.0m	DKK 2.01bn	DKK 2.05bn
Capital spending	−DKK 260.0m	−DKK 404.0m	−DKK 372.0m	−DKK 368.0m	−DKK 418.0m	−DKK 310.0m	−DKK 308.0m	−DKK 392.0m
Free cash flow	DKK 1.45bn	DKK 1.06bn	DKK 1.86bn	DKK 1.90bn	DKK 1.21bn	DKK 432.0m	DKK 1.70bn	DKK 1.66bn
Total assets	DKK 46.94bn	DKK 46.65bn	DKK 48.80bn	DKK 48.37bn	DKK 47.88bn	DKK 49.15bn	DKK 48.34bn	DKK 48.07bn
Cash and short-term investments	DKK 817.0m	DKK 1.07bn	DKK 1.13bn	DKK 947.0m	DKK 726.0m	DKK 729.0m	DKK 906.0m	DKK 788.0m
Debt	DKK 23.09bn	DKK 23.57bn	DKK 24.43bn	DKK 2.59bn	DKK 23.50bn	DKK 23.50bn	DKK 24.01bn	DKK 21.89bn
Shareholders' equity	DKK 13.37bn	DKK 12.84bn	DKK 13.80bn	DKK 16.12bn	DKK 16.45bn	DKK 16.94bn	DKK 15.46bn	DKK 17.94bn

Growth per year

Compound annual rate

	3 years	5 years	10 years
Revenue	7.3%	8.5%	7.2%
Operating income	5.6%	5.3%	5.3%
Net income	-8.2%	-2.8%	15.0%

Average margins

Over each period

	1 year	3 years	5 years	10 years
Gross margin	66.3%	66.9%	67.3%	67.5%
Operating margin	27.1%	27.6%	28.8%	29.4%
Net margin	15.8%	17.8%	19.4%	19.6%

Valuation history

At each fiscal year end

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Price to earnings	33.8	35.1	35.3	36.6	50.9	47.1	45.5	33.5	27.6	32.1
Price to sales	4.4	6.5	6.9	7.6	12.6	10.7	9.8	7.8	6.8	6.9

Dividends and splits

Per share, in the currency the company pays

Paid for 36 years. Last went ex-dividend on 18 May 2026.

	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Paid in the year	23.00	22.71	21.00	20.00	19.00	18.00	17.00	16.00

5-for-1 split · 19 Dec 2012
2-for-1 split · 16 Dec 2004
2-for-1 split · 19 Jan 2000
3-for-2 split · 29 Jan 1997
3-for-2 split · 20 Jan 1994
5-for-1 split · 24 Mar 1993

Sources and methodology

Data on this tab: Our data supplier
Chart on the Overview: TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.

Asset classes

Countries / Regions

Market tools

News & insights

Coloplast A/S COLO B.CO · DKK

Search any instrument

At a glance

Income statement

Balance sheet

Cash flow

Latest quarters

Growth per year

Average margins

Valuation history

Dividends and splits

Sources and methodology